(Q43631437)

25 November 2017

title

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study (English)

1 reference

invasive pulmonary aspergillosis

25 November 2017

0 references

1 reference

Joost Wauters

1

0 references

Greet Hermans

object named as

Greet Hermans

10

0 references

Wouter Meersseman

4

object named as

Wouter Meersseman

1 reference

25 November 2017

7

Katrien Lagrou

1 reference

25 November 2017

3

0 references

author name string

Ingrid Baar

2

1 reference

25 November 2017

Philippe Meersseman

3

1 reference

25 November 2017

Karolien Dams

5

1 reference

25 November 2017

Rudi De Paep

6

1 reference

25 November 2017

Alexander Wilmer

8

1 reference

25 November 2017

Philippe Jorens

9

1 reference

25 November 2017

publication date

16 August 2012

1 reference

25 November 2017

published in

Intensive Care Medicine

1 reference

25 November 2017

volume

38

1 reference

25 November 2017

issue

11

1 reference

25 November 2017

page(s)

1761-1768

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-012-2673-2

25 November 2017

exact match

0 references

cites work

H1N1: viral pneumonia as a cause of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Invasive aspergillosis after pandemic (H1N1) 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Isolation of Aspergillus in three 2009 H1N1 influenza patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Invasive aspergillosis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Pulmonary aspergillosis following post-influenzal bronchopneumonia treated with antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Lung pathology in fatal novel human influenza A (H1N1) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2673-2

A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis

21 January 2018

1 reference

12 December 2020

Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

1 reference

12 December 2020

Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.

1 reference

12 December 2020

Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during A (H1N1) infection

1 reference

12 December 2020

Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis

1 reference

12 December 2020

Influenza virus infection induces functional alterations in peripheral blood lymphocytes

1 reference

12 December 2020

Invasive aspergillosis in critically ill patients without malignancy

1 reference

12 December 2020

Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report

1 reference

12 December 2020

10.1007/S00134-012-2673-2

Identifiers

DOI

1 reference

25 November 2017

0 references

1 reference